Assessing the response of morphea and limited scleroderma to tranilast: a small prospective study comparing topical corticosteroids to a combination of topical corticosteroids and tranilast [PDF]
Clinical, Cosmetic and Investigational Dermatology, 2018 Rowland Noakes Queensland Institute of Dermatology, Greenslopes Private Hospital Campus, Greenslopes, QLD, Australia Background: Scleroderma is traditionally managed with immunomodulatory agents such as methotrexate, mycophenolate mofetil and ...
Noakes R
doaj +4 more sources
Evaluation of the optic nerve head vessel density in patients with limited scleroderma [PDF]
Therapeutic Advances in Ophthalmology, 2021 Objectives: To investigate the optical coherence tomography angiography (OCTA) parameters of the optic nerve head and peripapillary retina and to assess macular and peripapillary retinal nerve fiber layer (RNFL) thickness by using spectral-domain optical
Hilal Kılınç Hekimsoy +4 more
doaj +2 more sources
The value of ultrasound in the diagnosis of limited scleroderma – a case report [PDF]
Journal of Ultrasonography, 2015 Systemic sclerosis, popularly referred to as scleroderma, is a chronic connective tissue disease with present autoantibodies against platelet-derived growth factor receptor.
Grzegorz Pracoń +3 more
doaj +2 more sources
Cutaneous calcinosis in a patient with limited scleroderma: CREST Syndrome [PDF]
European Journal of Rheumatology, 2019 Abstract Cite this article as: Düzgün N. Cutaneous calcinosis in a patient with limited scleroderma: CREST Syndrome. Eur J Rheumatol 2017; 4: 305-6.
Düzgün N.
openaire +3 more sources
Phosphodiesterase-4 inhibition in localized scleroderma: A case series of topical roflumilast [PDF]
SAGE Open Medical Case ReportsLocalized scleroderma, or morphea, is a chronic fibrosing skin condition with limited therapeutic options, particularly for patients who are elderly, immunocompromized, or intolerant to systemic immunosuppressants.
Ghassan Barnawi +4 more
doaj +2 more sources
LICHEN SCLEROSUS OF THE VULVA IN PATIENTS WITH LIMITED SCLERODERMA
Клінічна та профілактична медицина, 2020 Modern literature information on the etiopathogenetic prevalence of lichen sclerosus has been presented by the authors; clinical manifestations and classification of the disease have been outlined; diagnosis and treatment issues have been discussed in ...
T.F. Tatarchuk +2 more
doaj +3 more sources
Severe Acro-osteolysis in a Case of Limited Cutaneous Scleroderma
Iranian Journal of Public Health, 2017 Please provide alternate text for this image to ensure accessibility for users with text-only browsers or assistive devices.
Milad HOSSEINIALHASHEMI +2 more
doaj +2 more sources
Implant-supported Collapsible Overdenture for Scleroderma Patients [PDF]
International Journal of Prosthodontics and Restorative Dentistry, 2021 Tightening of the skin around the oral aperture causes the mouth opening to become limited in scleroderma patients. The limited oral opening can make prosthetic treatment challenging.
Sheen S Mehta +3 more
doaj +1 more source
Intisari Sains Medis, 2021 Introduction: Scleroderma is a rare autoimmune disease of connective tissue characterized by extensive fibrosis, inflammation, and vasculopathy. It classified as limited cutaneous and diffuse based on the degree of skin involvement. The management is still a challenge since it has a high morbidity and mortality rate. This case report aims to understand
Putu Gde Hari Wangsa +2 more
openaire +1 more source
Early assessment of pulmonary involvement in limited scleroderma. A case report
The Turkish Journal of Pediatrics, 1998 Limited scleroderma is typified by insidious progression of skin involvement. The onset of internal organ involvement is delayed until the second decade, the lungs being the most important from the prognostic point of view.
E Unsal, O Kilinç, A Kargi, T Necla
doaj +3 more sources